Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 5 | 2020 | 17 | 2.010 |
Why?
|
Rural Population | 15 | 2022 | 624 | 1.700 |
Why?
|
Obesity | 4 | 2021 | 356 | 0.760 |
Why?
|
Overweight | 2 | 2018 | 84 | 0.700 |
Why?
|
Body Mass Index | 2 | 2018 | 312 | 0.650 |
Why?
|
Sex Factors | 3 | 2018 | 224 | 0.630 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 235 | 0.570 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 405 | 0.570 |
Why?
|
South Africa | 20 | 2022 | 7312 | 0.540 |
Why?
|
Risk Factors | 8 | 2021 | 1431 | 0.520 |
Why?
|
Humans | 24 | 2022 | 14077 | 0.470 |
Why?
|
Adult | 15 | 2022 | 5664 | 0.470 |
Why?
|
Female | 19 | 2022 | 8751 | 0.390 |
Why?
|
Adolescent | 10 | 2021 | 2858 | 0.390 |
Why?
|
Male | 15 | 2022 | 6489 | 0.370 |
Why?
|
Aged | 8 | 2020 | 1650 | 0.350 |
Why?
|
Helminths | 1 | 2009 | 1 | 0.340 |
Why?
|
Helminthiasis | 1 | 2009 | 7 | 0.340 |
Why?
|
Prevalence | 7 | 2018 | 1149 | 0.330 |
Why?
|
Population Surveillance | 4 | 2017 | 325 | 0.330 |
Why?
|
Middle Aged | 10 | 2020 | 3425 | 0.320 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 1377 | 0.320 |
Why?
|
Hypertension | 3 | 2017 | 397 | 0.310 |
Why?
|
Child | 5 | 2020 | 2180 | 0.310 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 137 | 0.290 |
Why?
|
HIV Infections | 7 | 2022 | 4946 | 0.280 |
Why?
|
Sexual Behavior | 2 | 2017 | 313 | 0.240 |
Why?
|
Young Adult | 6 | 2017 | 2357 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 2 | 2017 | 235 | 0.220 |
Why?
|
Academic Performance | 1 | 2022 | 1 | 0.210 |
Why?
|
Kenya | 2 | 2021 | 173 | 0.210 |
Why?
|
Surveys and Questionnaires | 2 | 2022 | 532 | 0.190 |
Why?
|
Depression | 1 | 2022 | 117 | 0.190 |
Why?
|
Burkina Faso | 1 | 2021 | 29 | 0.180 |
Why?
|
Student Dropouts | 2 | 2017 | 8 | 0.180 |
Why?
|
Students | 2 | 2022 | 48 | 0.180 |
Why?
|
Ghana | 1 | 2021 | 62 | 0.180 |
Why?
|
Sex Distribution | 2 | 2018 | 89 | 0.180 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 16 | 0.180 |
Why?
|
Seizures | 1 | 2020 | 20 | 0.180 |
Why?
|
Microbiota | 1 | 2020 | 30 | 0.180 |
Why?
|
Life Style | 1 | 2020 | 80 | 0.170 |
Why?
|
Social Support | 1 | 2020 | 76 | 0.170 |
Why?
|
Incidence | 3 | 2017 | 655 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 132 | 0.160 |
Why?
|
Rural Health | 2 | 2017 | 118 | 0.160 |
Why?
|
Healthy Lifestyle | 1 | 2018 | 9 | 0.150 |
Why?
|
Education | 1 | 2017 | 22 | 0.150 |
Why?
|
Geography | 1 | 2018 | 60 | 0.150 |
Why?
|
Anthropometry | 1 | 2018 | 101 | 0.140 |
Why?
|
Social Class | 1 | 2018 | 72 | 0.140 |
Why?
|
Herpes Genitalis | 1 | 2017 | 42 | 0.140 |
Why?
|
Awareness | 1 | 2017 | 18 | 0.140 |
Why?
|
Rural Health Services | 1 | 2017 | 48 | 0.140 |
Why?
|
Urban Health | 1 | 2017 | 78 | 0.140 |
Why?
|
Sexual Partners | 1 | 2017 | 211 | 0.130 |
Why?
|
Motivation | 1 | 2016 | 56 | 0.130 |
Why?
|
Status Epilepticus | 1 | 2015 | 1 | 0.120 |
Why?
|
Infant Mortality | 1 | 2015 | 92 | 0.120 |
Why?
|
Child Mortality | 1 | 2015 | 93 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 247 | 0.120 |
Why?
|
Malaria, Falciparum | 1 | 2015 | 39 | 0.120 |
Why?
|
Medicine, African Traditional | 1 | 2014 | 24 | 0.120 |
Why?
|
Blood Pressure | 1 | 2017 | 312 | 0.120 |
Why?
|
Mortality | 1 | 2015 | 101 | 0.120 |
Why?
|
Cause of Death | 1 | 2015 | 206 | 0.110 |
Why?
|
Medication Adherence | 1 | 2015 | 137 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2015 | 1410 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2020 | 409 | 0.110 |
Why?
|
Child, Preschool | 2 | 2015 | 1675 | 0.100 |
Why?
|
Aged, 80 and over | 1 | 2014 | 449 | 0.100 |
Why?
|
Hospitalization | 1 | 2015 | 392 | 0.100 |
Why?
|
Infant | 2 | 2015 | 2145 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2014 | 320 | 0.090 |
Why?
|
Cohort Studies | 3 | 2020 | 939 | 0.090 |
Why?
|
Host-Parasite Interactions | 1 | 2009 | 2 | 0.090 |
Why?
|
Central Nervous System | 1 | 2009 | 11 | 0.090 |
Why?
|
Virulence | 1 | 2009 | 25 | 0.080 |
Why?
|
Animals | 1 | 2009 | 1063 | 0.070 |
Why?
|
Africa South of the Sahara | 2 | 2018 | 328 | 0.070 |
Why?
|
Logistic Models | 2 | 2015 | 252 | 0.060 |
Why?
|
Retrospective Studies | 2 | 2017 | 767 | 0.050 |
Why?
|
Universities | 1 | 2022 | 34 | 0.050 |
Why?
|
Fasting | 1 | 2021 | 14 | 0.050 |
Why?
|
Glycated Hemoglobin A | 1 | 2021 | 24 | 0.050 |
Why?
|
African Americans | 1 | 2021 | 47 | 0.050 |
Why?
|
Blood Glucose | 1 | 2021 | 106 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 18 | 0.050 |
Why?
|
Feces | 1 | 2020 | 30 | 0.050 |
Why?
|
Bacteria | 1 | 2020 | 46 | 0.040 |
Why?
|
Pilot Projects | 1 | 2020 | 168 | 0.040 |
Why?
|
Cognition | 1 | 2020 | 75 | 0.040 |
Why?
|
Diet | 1 | 2020 | 108 | 0.040 |
Why?
|
Biomarkers | 1 | 2020 | 322 | 0.040 |
Why?
|
Qualitative Research | 1 | 2021 | 294 | 0.040 |
Why?
|
Exercise | 1 | 2021 | 203 | 0.040 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 11 | 0.040 |
Why?
|
Schools | 1 | 2017 | 67 | 0.040 |
Why?
|
Risk-Taking | 1 | 2017 | 119 | 0.040 |
Why?
|
Program Evaluation | 1 | 2017 | 89 | 0.040 |
Why?
|
Aging | 1 | 2017 | 109 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 217 | 0.030 |
Why?
|
Comorbidity | 1 | 2017 | 184 | 0.030 |
Why?
|
Herpesvirus 2, Human | 1 | 2016 | 42 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 39 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2017 | 190 | 0.030 |
Why?
|
Age Factors | 1 | 2017 | 364 | 0.030 |
Why?
|
Counseling | 1 | 2016 | 136 | 0.030 |
Why?
|
Antibodies, Protozoan | 1 | 2015 | 3 | 0.030 |
Why?
|
Marital Status | 1 | 2015 | 11 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2015 | 13 | 0.030 |
Why?
|
Unemployment | 1 | 2015 | 10 | 0.030 |
Why?
|
Burns | 1 | 2015 | 10 | 0.030 |
Why?
|
Educational Status | 1 | 2015 | 68 | 0.030 |
Why?
|
Brain Diseases | 1 | 2015 | 24 | 0.030 |
Why?
|
Uganda | 1 | 2015 | 194 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2014 | 171 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2015 | 243 | 0.030 |
Why?
|
Population Dynamics | 1 | 2012 | 27 | 0.030 |
Why?
|
Demography | 1 | 2012 | 105 | 0.020 |
Why?
|
HIV | 1 | 2014 | 380 | 0.020 |
Why?
|
Research Design | 1 | 2012 | 123 | 0.020 |
Why?
|
Health Policy | 1 | 2012 | 132 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2017 | 1275 | 0.020 |
Why?
|